Le Lézard
Classified in: Health
Subject: MRR

Genomics market size to increase by USD 18,244.34 million: Analysis of major players as well as the key contributor region - Technavio

North America will account for 37% of the global genomics market's growth 

NEW YORK, Jan. 30, 2023 /PRNewswire/ -- North America will account for 37% of the market's growth during the forecast period. The increase in research funding and the growing developments in precision medicine and personalized therapies are driving the growth of the regional market. The Genomics Market by Solution, Application, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 10.53% and register an incremental growth of  USD 18,244.34 million during the forecast period. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download a PDF Sample Report.

Company profiles

The genomics market report includes information on the key products and recent developments of leading vendors, including:

Market dynamics

The market is driven by factors such as rising investments in genomics research and development, reduction in the cost of genetic sequencing, and increasing demand for creating and upgrading genome databases. However, the varying regulations in genomics research and testing are hindering market growth.

Competitive analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share, among others. Request a Sample

Market segmentation

Related Reports:

Chromatography Market by Technology, End-user, and Geography - Forecast and Analysis 2023-2027: The chromatography market is estimated to grow at a CAGR of 6.82% between 2022 and 2027. The size of the market is forecast to increase by USD 3,785.83 million. The Increasing demand for ion exchange membranes for chromatography in R&D is notably driving the market growth, although factors such as product limitations the market growth. 

Forensic Technologies Market by Technique, Application, and Geography - Forecast and Analysis 2023-2027: The forensic technologies market is estimated to grow at a CAGR of 11.89% between 2022 and 2027. The size of the market is forecast to increase by USD 6,583.87 million. The increasing crime rate demanding better investigation methods is notably driving the market growth, although factors such as lack of technical know-how or technical professionals may impede the market growth.

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging
Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to
Technavio Insights

What are the key data covered in this genomics market report?

Genomics Market Scope

Report Coverage


Page number


Base year


Historic period


Forecast period


Growth momentum & CAGR

Accelerate at a CAGR of 10.53%

Market growth 2023-2027

USD 18244.34 million

Market structure


YoY growth 2022-2023 (%)


Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key countries

US, France, Germany, UK, and China

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

10X Genomics Inc., Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf SE, F. Hoffmann La Roche Ltd., Hamilton Bonaduz AG, Illumina Inc., Myriad Genetics Inc., New England Biolabs Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Promega Corp., QIAGEN NV, Standard BioTools Inc., Thermo Fisher Scientific Inc., and Perkin Elmer Inc

Market dynamics

Parent Market Analysis; Market growth inducers and obstacles; Fast-growing and slow-growing segment analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for Technavio "Health Care" Research Reports

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Solution

7 Market Segmentation by Application

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

SOURCE Technavio

These press releases may also interest you

at 04:02
Piramal Pharma Solutions, a patient-centric Contract Development and Manufacturing Organization...

at 04:00
Granular Therapeutics, (Granular) a private biotech company specialising in precision biologic therapies for treating mast cell driven disorders, today announces clinical candidate selection for its lead programme which has demonstrated promising...

at 03:58
The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting (the "Meeting"), to be held on Tuesday, 9 May 2023 at 15.00 at IVA Konferenscenter, Grev Turegatan 16, Stockholm,...

at 03:49
On March 29, 2023, Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK, hereinafter referred to as the "Company") released its annual financial results for 2022. During the reporting period, the Company's operating revenue increased by 87.8% YOY...

at 03:48
Selvita S.A. [WSE: SLV] ? one of the largest CRO (Contract Research Organization) companies in Europe has published a full-year report for 2022*. The Group reported record results for 2022, in excess of meeting the objectives of its ambitious...

at 03:30
TELUS Health (formerly LifeWorks), today released a special report on Financial Wellbeing as part of its Mental Health Index revealing workers in Canada are feeling uncertain about their financial future. Notably, the Index found that 26 per cent of...

News published on 30 january 2023 at 22:00 and distributed by: